Liver cancer
Conditions
Interventions
Control group:Usual care
Experimental Group:Usual care + thumbtack needle acupuncture combine with auricular acupressure
Sponsors
Zhongda hospital Southeast University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1)Liver cancer patients diagnosed by clinical physicians who require transarterial chemoembolization (TACE); 2)Aged 18 to 80 years; 3)No nausea or vomiting within 24 hours before TACE and no use of antiemetic drugs; 4)ECOG performance status score = 2; 5)Traditional Chinese medicine (TCM) syndrome differentiation indicates predominant symptoms of spleen and stomach deficiency with cold and liver qi stagnation; 6)Expected survival time > 6 months; 7)Voluntarily participate in this study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1)Patients with severe comorbid conditions such as heart liver kidney immune or hematologic system diseases; 2)Patients with malignant tumor brain metastases increased intracranial pressure gastrointestinal obstruction severe liver and kidney dysfunction or refractory 3)vomiting caused by brain tumors cerebrovascular diseases or other reasons; 4)Patients with diagnosed depression anxiety disorders psychiatric disorders or cognitive impairments; 5)Patients with lymphedema in the area where the acupoint patch treatment is applied; 6)Patients who cannot accept acupoint patch treatment due to allergies to Chinese medicine acupoint application or other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea Vomiting Grade;Nausea Vomiting Efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Life quality evaluation;Intensity of pain;TCM symptom scoring;Laboratory indicators; | — |
Countries
China
Contacts
Public ContactQi Zhang
Zhongda hospital Southeast University
Outcome results
None listed